Newsroom
Sorted by: Latest
-
Centuri Secures More Than $870 Million in New Commercial Awards Across North America
PHOENIX--(BUSINESS WIRE)--Centuri Holdings, Inc. (NYSE: CTRI) (“Centuri” or the “Company”), a leading, North American utility and energy infrastructure services company, today announced it has recently secured more than $870 million in new bookings, reflecting strong customer demand and associated investment in enabling energy infrastructure. Approximately $178 million of the bookings were achieved prior to year-end and represent growth in scope, bringing our total bookings for 2025 to $4.5 bil...
-
Blackstone Energy Transition Partners Announces Acquisition of Alliance Technical Group
NEW YORK--(BUSINESS WIRE)--Blackstone (NYSE: BX) announced today that funds affiliated with Blackstone Energy Transition Partners and other Blackstone funds (“Blackstone”) have acquired Alliance Technical Group (“ATG”), a leading provider of environmental testing, monitoring, and compliance services. Founded in 2000 and headquartered in Alabama, ATG has grown into one of the largest full-service environmental compliance providers in North America, with more than 2,200 employees located in 60-pl...
-
flyExclusive Expands Raleigh Presence with New One North Hills Office to Support Continued Growth
RALEIGH, N.C.--(BUSINESS WIRE)--flyExclusive today announced it has leased office space in the One North Hills Tower in Raleigh, North Carolina, marking a significant step in the company’s long-term growth strategy as it prepares for continued expansion in 2026 and beyond. The new Raleigh office will strengthen flyExclusive’s ability to attract top talent, enhance cross-functional collaboration, and accelerate execution as the company enters its next phase of disciplined growth. flyExclusive al...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NYSE Arca Biotechnology UCITS ETF 05.01.2026 FBTU.LN IE00BL0L0H60 525,002.00 USD 13,421,608.85 25.565 ...
-
Riassunto: Regula contribuisce con la competenza nel settore a due nuove relazioni di analisti sulle tendenze nelle frodi dei documenti e nella verifica dell'identità
RESTON, Va.--(BUSINESS WIRE)--Regula, sviluppatore globale di soluzioni di verifica dell'identità e dispositivi forensi, ha contribuito con la sua conoscenza esperta a due nuove relazioni di analisti curate da Forrester Research. Con più di 30 anni di esperienza nell'analisi di documenti forensi e decenni di collaborazioni con le agenzie di frontiera di tutto il mondo, Regula ha contribuito come esperto nel settore della scienza forense dei documenti e della verifica dell'identità. Il contribut...
-
Real to Present at the 28th Annual Needham Growth Conference
MIAMI--(BUSINESS WIRE)--Real to Present at the 28th Annual Needham Growth Conference...
-
Regula Contributes Industry Expertise to Two New Analyst Reports on Document Fraud and Identity Verification Trends
RESTON, Va.--(BUSINESS WIRE)--Regula, a global developer of identity verification solutions and forensic devices, has contributed its expert knowledge to two new analyst reports by Forrester Research. With more than 30 years of experience in forensic document examination and decades of collaboration with border agencies worldwide, Regula contributed as a domain expert in document forensics and identity verification. Contribution to “The State of Document Fraud Management” This report, authored...
-
Keysight Technologies Appoints Liz Morali as Head of Investor Relations
SANTA ROSA, Calif.--(BUSINESS WIRE)--Keysight Technologies, Inc. (NYSE: KEYS) today announced the appointment of Liz Morali as head of Investor Relations. Morali will lead engagement with Keysight’s global investor and analyst community and support clear, consistent communication of the company’s strategy, performance, and long-term growth opportunities. “Liz brings deep expertise in investor relations, capital markets, and executive communications, along with a strong understanding of the tech...
-
Fresenius Kabi Introduces New Presentation of Otulfi® (ustekinumab-aauz), a Biosimilar to Stelara®
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has introduced a new presentation of Otulfi® (ustekinumab-aauz) in a 45 mg/0.5 mL single-dose vial for subcutaneous injection. Otulfi® is a prescription medicine and the brand name for Fresenius Kabi’s FDA-approved biosimilar of the reference product, Stelara® (ustekinumab). With this addition, Fresenius Kabi now offers...
-
Samenvatting: Sectorexpertise van Regula als bijdrage aan twee nieuwe analyserapporten over trends in documentfraude en identiteitscontrole
RESTON, Va.--(BUSINESS WIRE)--Regula, een internationale ontwikkelaar van oplossingen voor identiteitscontrole en forensische hulpmiddelen, heeft haar expertkennis bijgedragen aan twee nieuwe analyserapporten van Forrester Research. Met meer dan 30 jaar ervaring in onderzoek van forensische documenten en decennialange samenwerking met douaneagentschappen over de hele wereld, droeg Regula haar steentje bij als domeinexpert in forensische documenten en identiteitscontrole. Bijdrage aan “The State...